Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Upcoming CR % @90 days = 71%? Extrapolation on 100 patients

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on Nov 25, 2022 9:49pm

295 Views

Post# 35129558

RE:RE:RE:Upcoming CR % @90 days = 71%? Extrapolation on 100 patients

I second those those thankyou's to CS and SF. I think that early 2023 will be very exciting. I would also add enriguesauve and Owen of Munster to the list of people on this board whose insights have been of great value.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism